JonathanJHoganMD

Instructor, Medicine, Columbia University College of Physicians and Surg

Dr. Hogan is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
3400 Spruce Street
1 Founders
Philadelphia, PA 19104
Phone+1 215-662-2638

New York Presbyterian Hospital (Cornell Campus)Fellowship, Nephrology, 2010 - 2012
University of Pennsylvania Health SystemResidency, Internal Medicine, 2007 - 2010
Perelman School of Medicine at the University of PennsylvaniaClass of 2007

PubMed

2 citations
A Core Outcome Set for Trials in Glomerular Disease: A Report of the Standardized Outcomes in Nephrology-Glomerular Disease (SONG-GD) Stakeholder Workshops.
Simon A Carter, Liz Lightstone, Dan Cattran, Allison Tong, Arvind Bagga
Clinical Journal of the American Society of Nephrology. 2022-01-01
28 citations
Recurrent Glomerular Disease after Kidney Transplantation: Diagnostic and Management Dilemmas
Audrey Uffing, Frank Hullekes, Leonardo V. Riella, Jonathan J. Hogan
Clinical Journal of the American Society of Nephrology. 2021-10-22
2 citations
A Focus Group Study of Self-Management in Patients With Glomerular Disease
Simon A. Carter, Claris Teng, Talia Gutman, Charlotte Logeman, Dan Cattran
Kidney International Reports. 2021-10-01

Journal Articles

DUET: A Phase 2 Study Evaluating the Efficacy and Safety of Sparsentan in Patients with FSGS
Howard Trachtman, Peter Nelson, Abanti Chaudhuri, Jai Radhakrishnan, Olga Zhdanova, Debbie S Gipson, Tarak Srivastava, Kenneth Lieberman, Vimal Kumar Derebail, Jonatha..., Journal of the American Society of Nephrology

Lectures

Monoclonal Gammopathies and Kidney Disease
American Society of Nephrology Kidney Week 2019 - Washington, D.C. - 11/7/2019

Travere Therapeutics to Host Virtual R&D Day on Wednesday, December 9, 2020December 1st, 2020
ZyVersa Therapeutics Enhances Scientific Advisory Board with Three Esteemed NephrologistsMay 15th, 2019